Arnaud I, Elkouri D, N'Guyen J M, Foucher Y, Karam G, Lepage J Y, Billard M, Potel G, Lombrail P
UPRES EA 1156: Thérapeutiques cliniques et expérimentales des infections, faculté de médecine de Nantes, 1, rue Gaston-Veil, 44000 Nantes, France.
Med Mal Infect. 2005 Mar;35(3):141-8. doi: 10.1016/j.medmal.2005.01.005. Epub 2005 Apr 20.
We analyzed the adequacy of antibiotic therapy prescribed for urinary tract infections (UTI): prostatitis, pyelonephritis, indwelling catheter-associated UTIs, or other undefined UTIs.
The adequacy of prescriptions to local guidelines was assessed retrospectively in two wards (Internal Medicine and Surgical Urology) of the Nantes University Hospital. The principal criteria involved simultaneously: choice of the molecule, dose, and treatment duration. Non-observances of guidelines were major (non-adequacy of the molecule, prescription of a non-active molecule according to in vitro susceptibility tests, non-appropriate treatment abstention), or minor (non-justified treatment, non-justified bitherapy, no prescription of bitherapy when requested, no treatment adaptation when requested, too short or too long treatment length, dosage mistakes).
One thousand eighty-six infections were collected over a 24-month period. The overall rate of adequate prescriptions was 40.1% (46.6% in Internal Medicine and 36.5% in Surgical Urology). In Internal Medicine (226 non observance among 389 prescriptions), the ratio of major non-observance of guidelines was 9.8%. Among them, 44.7% were non-appropriate treatment abstentions. In Surgical Urology (539 non observance out of 695 prescriptions), non-observance related to treatment length were the most frequent. The ratio of major non-observance was 19.9%. Among them, non-adequacy of the molecule reached 60.7%. Non-justified treatment and non-appropriate bitherapies were frequent.
For both units, indwelling catheter-related UTIs and other UTIs accounted for more than 50% of the infections although not detailed in the local guidelines. Identifying and analyzing Non observance may lead to targeted correcting actions to improve prescription quality.
我们分析了针对尿路感染(UTI)所开具抗生素治疗的恰当性,这些尿路感染包括前列腺炎、肾盂肾炎、留置导管相关尿路感染或其他未明确的尿路感染。
在南特大学医院的两个科室(内科和泌尿外科)对符合当地指南的处方恰当性进行回顾性评估。主要标准同时涉及:药物选择、剂量和治疗时长。未遵循指南的情况分为严重(药物不恰当、根据体外药敏试验开具无活性药物、不恰当的治疗放弃)或轻微(不合理治疗、不合理的联合治疗、要求联合治疗时未开具、要求调整治疗时未调整、治疗时长过短或过长、剂量错误)。
在24个月期间共收集到1086例感染病例。处方总体恰当率为40.1%(内科为46.6%,泌尿外科为36.5%)。在内科(389例处方中有226例未遵循),严重未遵循指南的比例为9.8%。其中,44.7%为不恰当的治疗放弃。在泌尿外科(695例处方中有539例未遵循),与治疗时长相关的未遵循最为常见。严重未遵循的比例为19.9%。其中,药物不恰当占60.7%。不合理治疗和不恰当的联合治疗很常见。
对于两个科室而言,留置导管相关尿路感染和其他尿路感染占感染病例的比例超过50%,尽管当地指南中未详细说明。识别和分析未遵循情况可能会促使采取针对性的纠正措施以提高处方质量。